References
Adamec, C., & Gwinnell, E. (2008). Injection drug users. In The Encyclopedia of
Drug Abuse. New York: Facts on File. Retrieved February 19, 2020, from
online.infobase.com/Auth/
Index?aid=18199&itemid=WE48&articleId=110098
Allyn, B., (2019). Judge Rules Planned Supervised Injection Site Does Not Violate
Federal Drug Laws. Retrieved from
https://www.npr.org/2019/10/02/766500743/judge-rules-plan-forsafehousedrug-injection-site-in-philadelphia-can-go-forwar
American Medical Association. (2017). AMA wants new approaches to combat
synthetic and injectable drugs. Retrieved from https://www.ama-assn.org/
Behrends, C. N., Paone, D., Nolan, M. L., Tuazon, E., Murphy, S. M., Kapadia, S.
N., … Schackman, B. R. (2019). Estimated impact of supervised injection
facilities on overdose fatalities and healthcare costs in New York City. Journal
of Substance Abuse Treatment, (106), 79-88. doi:
https://doi.org/10.1016/j.jsat.2019.08.010
Centers for Disease Control and Prevention. (2019a). Summary of Information on
The Safety and Effectiveness of Syringe Services Programs (SSPs). Retrieved
from https://www.cdc.gov/
Centers for Disease Control and Prevention. (2019b). Viral Hepatitis Surveillance
– United States, 2017. Retrieved from https://www.cdc.gov/
Centers for Disease Control and Prevention. (2020a). HIV and People Who Inject
Drugs. Retrieved from https://www.cdc.gov/
Centers for Disease Control and Prevention. (2020b) HIV in the United States and
Dependent Areas. Retrieved from https://www.cdc.gov/
Centers for Disease Control and Prevention. (2020c) Injection Drug Use and HIV
Risk. Retrieved from https://www.cdc.gov/
Centers for Disease Control and Prevention. (2020d). Opioid Overdose. Retrieved
from https://www.cdc.gov/
Centers for Disease Control and Prevention. (2020e) Syringe Services Programs
(SSPs) Determination of Need. Retrieved from https://www.cdc.gov
Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P.,
… Larney, S. (2017). Global prevalence of injecting drug use and
sociodemographic characteristics and prevalence of HIV, HBV, and HCV in